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DIFFERENT METHODS OF MEASURING NEUTRON DOSE/FLUENCE
GENERATED DURING RADIATION THERAPY WITH MEGAVOLTAGE BEAMS
Bagher Farhood,1 Mehdi Ghorbani,2 Nouraddin Abdi Goushbolagh,3 Masoud Najafi,4 and Ghazale Geraily5
Abstract—Medical linear accelerators (linacs) are the most fre-
quently applied radiation therapy machines in the locoregional
treatment of cancers by producing either high-energy electron
or photon beams. However, with high-energy photons (>8 MeV),
interaction of these photons with different high-Z nuclei of mate-
rials in components of the linac head unavoidably generates neu-
trons. On the other hand, the average energy of these generated
neutrons has almost the highest radiation-weighting factor.
Therefore, the produced neutrons should not be neglected. There
are various tools for the measurement of neutron dose/fluence
generated in a megavoltage linac, including thermoluminescent
dosimeters, solid-state nuclear track detectors, bubble detectors,
activation foils, Bonner sphere systems, and ionization chamber
pairs. In this review article, each of the above-mentioned dosimet-
ric methods will be described in detail.
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INTRODUCTION
CANCER IS the main cause of death in developed countries
and the second main cause of death in developing countries
(ACS 2011). Based on the estimation of the International
Agency for Research on Cancer (IARC), approximately
12.7 million cancer cases and 7.6 million cancer deaths
occurred in 2008, with 56% of the cases and 64% of the
deaths occurring in developing countries (ACS 2011;
Ferlay et al. 2010). Cancer is treated with surgery, radiation
therapy, chemotherapy, hormone therapy, targeted therapy,
and biological therapy (Garcia et al. 2007).
Radiation therapy is often considered to be the first
modality for the treatment of patients with cancer, particu-
larly those with unresectable tumors. Radiation therapy,
compared with other treatment modalities, provides numer-
ous advantages, including noninvasiveness, spatiotemporal
flexibility in tumor targeting, and organ preservation (Ahn
and Brown 2009).
Medical linear accelerators (linacs) are the most widely
applied radiation therapy machines in the locoregional treat-
ment of cancers by producing either high-energy electron or
photon beams (Biltekin et al. 2015). High-energy photons
have several advantages over the lower-energy ones, includ-
ing more skin sparing, higher depth-dose, higher uniformity
in isodose curves, and smaller scattered dose to tissues adja-
cent to the target volume (Khan 2014). However, with high-
energy photons (>8 MeV), the interaction of these photons
with different high-Z nuclei of materials in components of
the linac head unavoidably generates neutrons (Falcao
et al. 2007). In addition, photoneutrons are generated in
the body of the patient and in the room ceiling, floor, and
bunker walls. Neutron production in the linac head is
especially important due to the presence of a large number
of high-Z materials and their larger cross sections for
photoneutron production (Ma et al. 2007). On the other
hand, absorption cross sections of materials in the accelerator
head are too small for the produced neutron energies.
Therefore, the linac’s collimators do not shield neutrons, and
the neutrons can reach the patient. In routine radiotherapy
treatments, this extra dose is not taken into account (Pena
et al. 2005; Zanini et al. 2004).
The International Commission on Radiological Protec-
tion (ICRP) in Report 103 has established high values of
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radiation-weighting factors (wR) for neutrons, providing a
base for the biological effects of photoneutrons generated in
radiation therapy linacs with maximum effect on the
calculations of effective dose and equivalent dose (ICRP
2007). On the other hand, there is a growing concern about
the risk of secondary tumors induced by radiation as a
consequence of radiation therapy treatments (Sánchez-
Doblado et al. 2012). On this subject, there is a
comprehensive review article by Xu et al. (2008) explaining
the principles, methods, and unresolved issues.
Leakage and scattered photons as well as secondary
neutrons are responsible for the peripheral undesirable
dose. The out-of-field dose related to photons is generally
higher than the neutron absorbed dose, but due to the
higher wR of neutrons, they may be the predominant
source of tissue damage related to secondary radiation in
some cases (Bednarz et al. 2009; Kry et al. 2005).
Therefore, in radiotherapy with photons >8 MeV, it is
useful to know the neutron dose equivalent per unit
therapeutic dose in the treatment room, in order to design
appropriate shielding for the bunker as well as to assess
the equivalent dose received by patients (Howell et al.
2005a, b). There are various methods for the measurement
of neutron dose/fluence generated in megavoltage linacs
as identified in the present study.
IMPORTANCE OF NEUTRON DOSIMETRY
Advances in the technology of radiotherapy have
resulted in radiation treatments with high-energy and high-
radiation doses (Park et al. 2013). The application of pho-
tons with higher energies increases the probability of
radiation dose being received by critical organs from
photoneutrons and secondary photons. However, with the
advent of intensity-modulated radiation therapy (IMRT),
aiming at more precise dose delivery to the tumor and pre-
serving the neighboring tissues, the used monitor unit is
usually 2 to 4 times more than that of conventional treat-
ments. In addition, a multileaf collimator (MLC) is present
in the accelerator head, which may lead to even higher neu-
tron contamination in combination with high energies
(Vanhavere et al. 2004).
Another important concern is the radiation-weighting
factor related to the ratio of the biological effect of radiation.
The average energy of the generated neutrons is estimated
to be ~1 MeV (McGinley and Landry 1989; Zanini et al.
2004), which is in the energy range related to the greatest
quality factor for neutrons (Kereiakes and Rosenstein 1980).
The radiation-weighting factor equals 1 for beta and gamma
radiation, 20 for alpha radiation, and 5–20 for neutron radia-
tion, depending on the energy. Therefore, the produced neu-
trons should not be neglected (Schauer and Linton 2009).
Since, in treatment planning, the dose-related neutrons
generated in a linac are typically ignored, it is important to
simultaneously assess the treatment dose to patients and
the dose related to secondary radiation, such as neutrons.
In other words, the dose received by the patient is affected
by neutrons in the irradiation area, and if the dose from neu-
trons can be measured, it will be possible to provide more
precise and accurate treatment. Consequently, regulations
and laws have been established for medical linacs to provide
standards for the photons and neutrons that leak from the
head part (Park et al. 2013).
PROBLEMS RELATED TO NEUTRON
DOSIMETRY IN RADIOTHERAPY
The active characterization of radiotherapy rooms is
complex because of the high x-ray background and the
pulsed nature of the mixed photon-neutron field. Therefore,
the use of passive detectors has been suggested to avoid the
instrumental problems of active detectors such as signal
pileup (Nath et al. 1986). There are several passive methods
based on thermoluminescent dosimeters (TLDs) (Barquero
et al. 2005), activation of foils in Bonner spheres (García
Fusté 2010), superheated bubble emulsions (Vaijapurkar
et al. 2008), etc. These methods are not widely applied in
clinical facilities because they are time consuming, as the
detectors need to be read out in an external laboratory after
exposure. There are two chief challenges to the application
of active detectors: (1) mixed photon-neutron fields are
pulsed (hundreds of hertz), and the high gamma field may
well trigger signal pileup; and (2) the photon fluence may
be very high inside the treatment room, thereby preventing
the application of standard detectors to discriminate be-
tween the x-ray background and the neutron signal. For
these reasons, extended use of active or on-line monitoring
of the neutron field in radiotherapy rooms has not been
performed (Guardiola et al. 2013). Of course, in recent
years, researchers have made efforts to use active detec-
tors in neutron dosimetry. For example, Gómez et al.
(2010) introduced a reliable method based on the interac-
tion of neutrons with borophosphosilicate glass in static
random-access memory (SRAM) cells, which is insensi-
tive to the photon fluence and allows for the measurement
of the slow neutron radiation field. Another study by
Guardiola et al. (2013) presented a standard detector with
an active method of measuring neutrons around a medical
linac applying an ultrathin silicon detector with three-
dimensional electrodes adapted for neutron detection.
VARIOUS METHODS FOR NEUTRON
DOSIMETRY IN RADIOTHERAPY
There are various methods for the measurement of
neutron dose/fluence generated in megavoltage linacs,
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including TLDs, solid-state nuclear track detectors
(SSNTDs), bubble detectors, activation foils, Bonner
sphere systems (BSSs), and ionization chamber pairs. In
this review article, each of these dosimetric methods will
be discussed in detail. Different neutron detection/
dosimetric characteristics of these detectors/dosimeters
are summarized in Table 1.
Thermoluminescent dosimeters
TLDs are small lithium fluoride crystals applied as pas-
sive and integrating detectors. After exposure, information
related to the radiation exposure can be elicited by heating
the detectors and reading out the emitted light yield
(Stokkevåg 2010). The principles and physical mechanisms
of thermoluminescent dosimetry have been explained by
Oberhofer and Scharmann (1981). TLDs are currently ap-
plied to measure absorbed dose from various radiation
fields in medical and industrial applications. Different ther-
moluminescent materials have been developed to improve
their sensitivities to different radiation beams (such as photons,
protons, electrons, alpha particles, and thermal neutrons) and
also to enhance the performance of these detectors (Bilski
et al. 1994; Horowitz 1990; Nakajima et al. 1979, 1978;
Pradhan and Bhatt 1989; Ziying et al. 1986).
Since photons contribute to the thermoluminescence
signal of the dosimeters, and the dosimeters are exposed
to a mixed photon-neutron field, it is difficult to measure
neutron fluence with a single dosimeter. Therefore, the In-
ternational Commission on Radiation Units and Measure-
ments (ICRU) in Report 26 (1977) has recommended that
a suitable pair of dosimeters should be used, with one of
them being more sensitive to photons and the other one
more sensitive to neutrons, as they are required to discrimi-
nate the contributions of neutrons and photons in a mixed
field. The selected TLD pairs that are generally used tomea-
sure the dose in a photon and thermal neutron mixed field
are 7LiF:Mg,Ti (TLD-700) and 6LiF:Mg,Ti (TLD-600).
TLD-600 has been enriched with 6Li which has a large
cross section of ~940 b for reaction with thermal neutrons
(6Li(n,a)3H). In this reaction, the emitted secondary parti-
cles with high linear energy transfer (LET) (2.07MeValpha
particles and 2.24 MeV tritons) release their energies inside
the dosimeter. TLD-700 enriched with 7Li has very weak
interaction with thermal neutrons. Therefore, TLD-600 is
more sensitive to thermal neutrons than TLD-700. On the
other hand, the sensitivity of both TLDs to photons is ap-
proximately the same, because the interaction of photons
with TLDs depends on the atomic numbers of the atoms in-
side the dosimeters and not on the atomic masses of the
atoms inside the dosimeters. Therefore, the use of TLD
pairs seems to be a good option for determining thermal
neutron dose in a medical linac field.
There are several chips, such as GR200A, MCP, and
TLD-100H (differing in their dopant concentration), that
have high sensitivity, good tissue equivalence, low-Z phos-
phor, and 20–50 times higher thermoluminescent sensitivity
than the widely applied LiF:Mg,Ti (TLD-100) dosimeter
materials for photons. Consequently, these chips can be
used instead of TLD-700. For example, Triolo et al.
(2007) investigated the pair response of MCP-TL-600 in
comparison with that of TLD-700 and TLD-600 to deter-
mine the components of a photon-neutron mixed field in
the fluence range for radiotherapeutic applications. They
concluded that the fluence value acquired by the MCP and
TLD-600 pair is as accurate as the value acquired by the
most common TLD-700 and TLD-600 pairs.
It has been shown that the uncertainties of the TLDs are
in the range of 2.5% (TLD-600) to 5.5% (TLD-700). The
TLDs have a quite wide linear response, ranging from
10 mGy to 10 Gy. Deviations from linearity are <12% for
TLD-700 and <9% for TLD-600. A measure of thermal
neutron sensitivity by an in-phantom cross calibration using
Table 1. Detection/dosimetric characteristics of neutron detectors/dosimeters.
Detector/dosimeter type
Neutron detection/dosimetric characteristics
Neutron energy
Linear
dose response
Photon
discrimination Active or passive References
TLD Thermal 10 mGy–10 Gy Good Passive
Stokkevåg 2010;
Bagheri et al. 2018
CR-39 40 keV–40 MeV 0.2 mSv–250 mSv Excellent Passive
Jaradat and
Biggs 2008
Bubble detector 0.2 MeV–15 MeV 1.0 mSv–0.02 mSv Excellent
Active or
passive
Biltekin et al. 2015
Activation foils 0.025 eV–>20 MeV — Excellent Passive Simakov et al. 2007
BSS 0.025 eV–>20 MeV
Can vary depending
on their sensor
system
Excellent or good
(depending on their
sensor system)
Active or
passive
Thomas and
Alevra 2002
Ionization chamber
Thermal,
epithermal, fast
— Good Active
Burmeister et al. 1999;
Becker et al. 2007;
Kosunen et al. 1999
67Measuring neutron dose/fluence generated in radiotherapy c B. FARHOOD ET AL.
www.health-physics.com
Copyright © 2019 Health Physics Society. Unauthorized reproduction of this article is prohibited.
a 15MVphoton beam showed that the neutron sensitivity of
the TLDs after subtracting the photon component of the sig-
nalwas (1.1 ± 0.5) 10−5 nC (n cm−2)−1 (Stokkevåg 2010).
The vast application of TLDs is due to both their tissue
equivalence and small dimensions for most types of radia-
tions (Triolo et al. 2007). In addition, these detectors do not
need any electronic devices during exposure (Stokkevåg
2010). Nevertheless, TLD pairs do not seem to be reliable
tools for the measurement of neutron dose inside the radia-
tion field because of the high photon flux (Nedaie et al.
2014). Another limitation is that these TLD pairs are usually
used for the measurement of thermal neutrons (Bagheri
et al. 2018; Triolo et al. 2007).
Solid-state nuclear track detectors
The SSNTD was discovered by Young (1958). These
detectors have successfully been employed for ion particle
and neutron detection (Nikezic and Yu 2004). SSNTDs are
capable of registering charged particles by the radiation-
induced damage caused along their interaction path. The
damaged regions generated by radiation on the detectors
are developed and amplified to be visualized with an optical
microscope by a well-reported technique (e.g., chemical
etching) (Castillo et al. 2013).
Depending on the energy of the neutrons that need to
be measured, different SSNTDs can be applied. Commonly
used instruments for neutron measurement are polyallyl
diglycol carbonate (PADC) or CR-39, polycarbonate films,
cellulose nitrate (LR-115), etc. From among these, the most
sensitive and widely used device is the PADC, generally
known by its trademark CR-39, detector (Jain et al. 1997;
Sahoo et al. 2012; Singh et al. 2009; Virk and Singh
1994). CR-39 has been widely applied as a personal dosim-
eter for thermal and fast neutrons. The basic mechanism of
detection for track-etch neutron dosimetry systems is etch-
ing the tracks of secondary charged particles since the neu-
tron, by itself, leads to no direct ionization (Pal et al. 2009).
When secondary particles collide with the polymeric struc-
ture of CR-39, the chemical bonds of CR-39 are broken and
latent tracks are created. To convert the latent tracks to visible
tracks, the etching process should be performed. There are
several etching methods such as chemical etching (CE), elec-
trochemical etching (ECE), and microwave-induced chemi-
cal etching (MICE) (Singh et al. 2009; Tripathy 2015).
On the other hand, each of these methods has its own
advantages and disadvantages over other methods. For
example, application of the ECE technique generates short-
range tracks from low-energy protons visible at lowmagnifi-
cation (Harvey et al. 1997). At high doses where the track
density is too high for being counted by ECE, the CE system
provides a solution (Harvey et al. 1997). The ECE system is
useful over the dose-equivalent range from 0.2 mSv to
10 mSv. The dose equivalent range of CR-39 dosimeters
can be extended up to 100 mSv by the CE system; therefore,
exposures >10 mSv can be estimated by the CE system. In
addition, the CE process is simple since it does not require a
high-voltage power supply. The disadvantages of the CE pro-
cess include being more time consuming and cumbersome for
track counting using an optical microscope (Pal et al. 2009).
Neutron measurements by SSNTDs are performed ei-
ther directly for fast neutrons by recording the recoil particles
due to neutron scattering with plastic compounds (H, C, and
O) (Widell and Svansson 1973) or indirectly for intermediate
and thermal neutrons using converters enriched with 10B or
6Li to generate alpha particles through the (n,a) reaction
(El-Khatib et al. 1994).
Some parameters play a significant role in the improve-
ment of the sensitivity of CR-39 detectors, such as the type
of etching system and its conditions, the use of radiators or
converters, and the manufacture of the detector (El-Khatib
et al. 1994). In a study by El-Khatib et al. (1994), the sensi-
tivity of the CR-39 detector in fast, intermediate, and thermal
regions was estimated to be 1.67  10−4, 3.41  10−4, and
6.75 10−3 tracks per neutron, respectively. They concluded
that CR-39 covered with 80 mm polycarbonate and LiF can
be used as a good detection technique with sufficient accu-
racy for neutron dosimetry in a very wide energy range
from 0.025 eV to 14.5 MeV.
Several advantages of CR-39 include high sensitivity
to a wide range of neutron energy using the recoil proton
mechanism; insensitivity to gamma, beta, ultraviolet (UV),
and x-ray radiation over a wide range of doses; no postirra-
diation fading of the produced tracks due to environmental
conditions; permanent recording of the tracks of ionizing
particles in insulating solids; and ease of reading nuclear
tracks which can be revealed by simple methods of etching
and viewing nuclear tracks using simple imaging systems.
Additionally, CR-39’s lower energy threshold at 100 keV
for neutrons makes it most appropriate for personnel neu-
tron monitoring in fuel-reprocessing facilities and reactor
environments (Pal et al. 2009; Castillo et al. 2013).
Several drawbacks exist for this type of dosimeter
such as the possibility of breakage and scratches. The ma-
jor problem, however, is its time-consuming and cumber-
some track development process and readout procedure
(Pal et al. 2009).
Bubble detectors
The bubble detector trajectory was started in 1952 by
Glaser (1952) to detect electrically charged particles moving
through it. Based on Glaser’s study on the reactions in su-
perheated liquids exposed to ionizing radiation, Apfel
(1979) created a neutron detector containing superheated
emulsion, extralarge or droplet halocarbon vaporized by
high-LET recoil nuclei due to interaction with neutrons.
Five years later, Ing and Birnboin suggested the use of
68 Health Physics January 2020, Volume 118, Number 1
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polymer as an environment for superheated emulsion
(D’Errico and Alberts 1994). The principles and physical
mechanisms of bubble detectors have been explained by
Stokkevåg (2010).
Neutron measurement is the most important applica-
tion of these detectors. Bubble detectors can be active or
passive (Ramalho et al. 2009). The passive group for per-
sonal dosimetry presents high sensitivity and provides re-
sponses of dose equivalent accompanied by discrimination
of photons (Rosenstock et al. 1995) as well as discrimina-
tion of any possible protons (Ing et al. 1997).
Bubble detectors use thousands of microscopic, super-
heated, suspended droplets in an elastic polymer medium
with a radius of <100 mm, maintaining the adjusted temper-
ature and pressure as the droplets become metastable
(Stokkevåg 2010). In the absence of a neutron field, the
microdroplets are able to remain in the liquid state above
their normal boiling point for several months.When enough
energy is deposited in a localized region of the droplets,
bubble nucleation occurs. While charged recoils produce
trails of microscopic vapor cavities within the droplets, only
those exceeding a minimum critical size can be developed
as macroscopic bubbles. When the droplet reaches this size,
the expansion becomes irreversible, and all droplets evapo-
rate. The number of generated bubbles is proportional to the
neutron equivalent dose (Biltekin et al. 2016; D’Errico et al.
1998a). When irradiation of the detector is finished,
counting of the produced bubbles can be started, which
can be performed either manually with optical readers using
image analysis software programs, or with other automatic
methods (Ramalho et al. 2009). The counting procedures
have been explained by Ramalho et al. (2009). After the
reading process, the detectors are recompressed to convert
bubbles back into droplets (Biltekin et al. 2016).
It was reported that the bubble detector is insensitive to
photon energies <25MV, while its neutron threshold energy
is 0.1 MeV with a reasonably flat response in the dose
equivalent range of 0.2 MeV to 15 MeV. Therefore, it
is sensitive only to fast neutrons (Lin et al. 2007;
Vanhavere et al. 2004). Additionally, the detector sensi-
tivity is about 500 to 1,000 bubbles mSv−1 (Bubble
Technology Industries Inc. 2010). In another study by
Ipe and Busick (1987), the neutron response character-
izations of these detectors at both electron and photon
beams have been evaluated.
There are some advantages of bubble detectors, includ-
ing being completely insensitive to photon fluence, com-
pact, lightweight, robust, and tissue equivalent, and having
an isotropic response. Detectors of the passive type can be
applied in pulsed radiation fields. Bubble formation is ap-
proximately independent of neutron energy in the energy
range of 0.3–10 MeV. In addition, it can directly measure
dose equivalent without needing any prior knowledge of
the neutron energy spectrum (D’Errico et al. 1998b; Jaradat
and Biggs 2008; Mameli et al. 2008; Ramalho et al. 2009).
Although the bubble detector was recognized as one of
the most accurate and sensitive neutron dosimeters, it has
several disadvantages, including limitation of the dynamic
range of the detector (Ing 2001) as well as temperature de-
pendence. To minimize uncertainties based on temperature
variations, temperatures of the treatment room and the de-
tector should be kept constant. Another limitation of the
bubble detector is dependence of the detector response on
themeasured neutron energy (Biltekin et al., 2015). Further-
more, another limitation is that the counting process may
become very difficult when the number of bubbles is high.
Of course, such an increase is necessary because generating
more bubbles in the detectors results in reduction of the sta-
tistical uncertainty related to neutron dose measurements
(D’Errico et al. 2008).
Activation foils
Activation foils are passive detectors and are composed
of different types of materials, such as silver, manganese,
and gold. When they are exposed to neutron radiation, the
neutrons in the active foils are absorbed, and if the neutron
energy is sufficient, they induce radioactivity in the irradi-
ated materials that can be eventually measured by an appro-
priate counter (Stokkevåg 2010). Using different active foils
with various nuclear reaction energy thresholds, the spec-
trum of the neutrons can be determined (Turner 2008).
Table 1 presented by Simakov et al. (2007) demonstrates
the elements and neutron reactions which may be appro-
priate for this purpose. These detectors are in the form of
disks with thicknesses ranging from 125 mm to 2 mm and
diameters from 2 mm to 22 mm, produced from materials
of high purity (at least 99% pure) (Casoli et al. 2016).
For example, when foils of gold are irradiated with
thermal neutrons, 198Au atoms are created following the neu-
tron capture reaction 197Au(n,g)198Au, and the cross sec-
tion for this reaction is 9,888 b at 0.025eV energy. They
decay in a cascade of beta/gamma decays with the pre-
dominant emission of gamma rays with the energy of
411 keV (t1/2 = 2.7 d). After irradiation, the photopeak of
411 keV for gamma rays is measured for each foil by a suit-
able detector (e.g., NaI(Tl) scintillation detector), and
thereby the corresponding saturation activity is calcu-
lated. When photons with energies beyond 8 MeV are
used in the irradiation field, 196Au atoms are formed by
the 197Au(g,n)196Au reaction, giving photopeaks at 333
keV, 356 keV, and 426 keV. It is notable that the energy res-
olution of the NaI(Tl) system allows the most intense 196Au
peak (356 keV) to be separated from 198Au (411 keV), and
therefore, the relative intensities of the mixed neutron-
photon components in the irradiation field can be calculated
(Fernandez et al. 2007).
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Since foil activation is a reliable method, it is a simple
technique for measuring the epithermal and thermal compo-
nents of the neutron flux in radiation therapy rooms. The
major advantage of activation detectors is insensitivity to
photon radiation in a mixed radiation field of both photon
and neutron radiation. Other advantages of these detectors
include their low cost and small sizes, leading to superior
spatial resolution for the separation of neutron doses. How-
ever, the basic disadvantage of these detectors is that the ac-
tivity induced in them should be measured in a separate
system of gamma counting, which must be installed far
away from the treatment room (Yücel et al. 2016).
Bonner sphere systems
BSSs are applied to measure neutron spectra in mixed
neutron-photon fields. This spectrometer was first intro-
duced by Bramblett et al. (1960). The BSS has a central
thermal neutron detector surrounded by spheres of various
sizes and hydrogenous material (moderators) (Maglieri
et al. 2015). This combination (thermal sensor plus moder-
ating sphere) is sensitive to neutrons over a wide energy
range. For each sphere, the sensitivity reaches its maximum
at a specific neutron energy depending on the diameter of
the sphere. Information related to the measured readings
of a set of combinations can be used to obtain the spectrum
of the neutron field. It is notable that it is difficult to extract
this spectral information, and the validity of BSS results has
mostly been questioned (Thomas and Alevra 2002). There
are various types of thermal neutron detectors at the central
sensor of the BSS; for example, 6LiI(Eu) scintillators, gold
or dysprosium activation foils, nuclear track detectors, and
TLD pairs. The appropriate choice of thermal detector
may affect the performance of the BSS even in very intense
photon fields, e.g., in linacs. The acquisition system is gen-
erally simple and based on a counting chain for active coun-
ters or spectrometers, whereas for passive detectors such as
activation foils, nuclear track detectors, or TLD pairs, these
detectors have to be removed from the sphere after the irra-
diation, and then the results must be analyzed. Analysis of
activation foils may be performed in situ, when portable
counting systems are available (Bedogni 2011). For in-
stance, gold as an activation material and central sensor in
the BSS is the most common material applied to measure
the contaminant neutron spectrum in the vicinity of a linac
(Thomas et al. 2007).
The BSS is surely the most applied spectrometer for
applications in radiation protection due to its advantages, in-
cluding: (1) the excellent energy range, since it is the only
available spectrometer which can cover the energy range
from thermal to GeV; (2) good sensitivity in comparison
with other neutron spectrometers, which can be varied by
changing the thermal sensor; (3) good photon discrimina-
tion, since the choice of an appropriate sensor system can
be insensitive to photons, even in the presence of intense
photon fields; (4) isotropic angular response, since it does
not require information about the neutron field direction;
and (5) the generally simple acquisition system (based on
a counting chain for active counters or spectrometers),
which does not need really complex electronics but can be
time consuming (Bedogni 2011; Thomas and Alevra 2002).
However, there are several disadvantages of the BSS,
including poor energy resolution, due to the shape of
the response functions characterized by overlapping and
similarities (Bedogni 2011; Thomas and Alevra 2002).
It was shown that the best energy resolution is in the range
of 0.1 to 20MeV, whereas poor energy resolution is found
in the intermediate energy region and beyond 20 MeV
(Reginatto 2002). Other limitations of BSSs include the
weight and large volume of the detector entailed by the
set of spheres. In addition, the spheres are required to be
sequentially irradiated, generally prolonging measure-
ment sessions (Bedogni 2011). The spectrum-unfolding
process has the potential for errors, as the most complex
aspect of the spectrometry task is this process because
of the nonuniqueness of the mathematical solutions
(Bedogni 2011; Thomas and Alevra 2002).
Ionization chambers
Lüdemann et al. (1995) introduced a specific ioniza-
tion chamber to study thermal neutron flux. This chamber
is a magnesium chamber with a coating of enriched 10B
within the chamber cavity. Later, Burmeister et al. (1999)
applied the same principle. They used a paired Mg(10B)
and Mg ionization chamber system at a fast neutron beam.
The separation of dose components can be performed by a
triple chamber system with a tissue equivalent chamber,
and shielded and unshielded Geiger-Muller counters in a
fast neutron beam (Schmidt and Hess 1982). Recently, a
study has used a triple chamber system to discriminate dose
components without requiring additional measurements by
foils or TLDs. They applied two magnesium ionization
and tissue equivalent chambers, with one of the magnesium
chambers enriched with 10B on its internal surface to en-
hance its response to thermal neutrons (Becker et al. 2007).
To employ a combination of a neutron insensitive and
tissue equivalent ionization chambers, photon and neutron
doses can be separately measured in a neutron beam
(Kosunen et al. 1999). The twin chamber system with a tis-
sue equivalent and a neutron insensitive magnesium chamber
has been in use for many years (ICRU 1976, 1989). This ion-
ization chamber system has been applied by Kosunen et al.
(1999) to separate neutron and photon doses in an epithermal
neutron beam. Moreover, this system is a commonly used
method for fast neutron dosimetry. Using the formula pre-
sented by ICRU related to twin ionization chambers,
doses from photon and neutron beams can be determined.
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There are several benefits of the ionization chamber
system: (1) the chambers do not suffer from dead time and
saturation effects practically; therefore, they can be applied
in relatively intense radiation fields as well as connected
to electrometers that are commonly used in oncology de-
partments; (2) the ionization chambers are common instru-
ments in the radiation therapy department; and (3) it has a
direct reading and relatively short measurement time
(Golnik et al. 2004). Nevertheless, the use of two or three
chambers or other detectors along with the ionization cham-
bers may limit their applications.
NEUTRON SPECTRUM AND DOSIMETRIC
PROPERTIES AROUND LINACS
Inside the treatment room of a high-energy linac, there
is a mixed radiation field resulting from photons and con-
tamination neutrons. The mixed radiation field spectrum is
modified because of the particles’ transport via linac mate-
rials as well as the treatment room walls (Kase et al. 1996;
Biggs 1998; Lin et al. 2001). The average energy of the pri-
mary neutron spectrum is in the range of 1 to 2 MeV. The
energy distribution of neutrons transmitted via the linac
head is more complex, as their spectra are severely degraded
and their average energies are commonly in the range of
0.2 to 2 MeV (McCall et al. 1984). It is reported that the
most biological effectiveness is related to neutrons with
energies beyond 100 keV to 2 MeV, as their radiation-
weighting factor is 20. Therefore, the neutron spectrum
around a linac confirms that most photoneutrons are gen-
erated at energies with high biological effectiveness
(Zanini et al. 2004; Schauer and Linton 2009). By know-
ing the undesirable neutron and photon spectra inside the
treatment room, the required data to specify better shielding
requirements is provided. Various methods have been used
to measure neutron spectra in mixed radiation fields, such
as Bonner sphere spectrometers, bubble dosimeters, and ac-
tivation detectors (Sanchez et al. 1989; Bourgois et al. 1997;
D’Errico et al. 1998a; Veinot et al. 1998; Bartlett et al. 1999;
Krmar et al. 1999; Vega Carrillo et al. 1999, 2001; Thomas
et al. 2002).
Several studies have measured neutron spectra around
linacs (D’Errico et al. 1998a; Barquero et al. 2005; Howell
et al. 2005a; Esposito et al. 2008). For instance, various
zones of the treatment room and the neutron spectrum
around an 18 MV linac are shown in Figs. 1 and 2, respec-
tively (Barquero et al. 2005). Based on these figures, the av-
erage photoneutron energy decreases with increasing
distance from the isocenter. The peak of the spectrum,
which is near 0.1 MeV, decreases upon moving away from
the linac head and disappears when the maze zone is
reached. The interior of the treatment room can be classified
into several parts, including the linac head, isocenter, maze
wall, and inner and outer doors. According to the data
Fig. 1. Different areas of linac treatment room: (a) head of linac, (b)
cranial wall, (c) caudal wall, (d) maze wall, (e) inner door, (f ) outer
door (reproduced with permission from Barquero et al. 2005).
Fig. 2. Neutron spectrum around an 18 MV linac: (a) head of linac,
(b) cranial wall, (c) caudal wall, (d) maze wall, (e) inner door.
(Reproduced with permission from Barquero et al. 2005).
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related to the neutron spectrum, it can be determined what
type of dosimeter is useful for each region. For instance,
TLDs, Bonner spheres, and active foils can be used for neu-
tron dosimetry in areas away from the isocenter (the maze
wall as well as the inner and outer doors) because the ther-
mal neutron flux is dominant in these regions. For in-field
areas, in which photon and neutron fluxes are very high,
the use of passive detectors is predominant due to the pileup
effect. In addition, since the fast neutron flux dominates in-
field areas and on the patient couch, CR-39, bubble detec-
tors (passive type), and ionization chambers can be em-
ployed. Although most detectors/dosimeters can be used
in different areas, they have been classified according to
their superior performance in terms of energy response to
neutrons.
CONCLUSION
Each dosimetric method for the measurement of neu-
tron dose/fluence around megavoltage linacs has its own ad-
vantages and disadvantages. Furthermore, each has almost
the highest sensitivity to the type of neutron (fast, thermal,
or epithermal). Therefore, the type of dosimeter must be
chosen considering the advantages and disadvantages of
each dosimetric method as well as the type of neutron
beams at which it will be used.
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